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ABSTRACT
Introduction: Food insecurity is a well-
established predictor of poor health outcomes.
Antiretroviral therapies (ARTs) that should be
taken with food to increase bioavailability may
further challenge food insecure patients. This
study examined factors associated with
antiretroviral adherence and HIV viral
suppression among people living with HIV
who are food insecure and prescribed
medications that require food.
Methods: A community sample of 313 men and
105 women who experienced food insecurity in
the previous month and were currently taking
ART completed computerized interviews, urine
screening for drug use, prospective biweekly
unannounced pill count adherence
assessments, and obtained their HIV viral load
and CD4 cell counts from medical records.
Results: Individuals taking ART regimens that
should be taken with food were significantly
more likely to be unemployed, were living
longer with an HIV diagnosis, had lower CD4
cell counts, poorer HIV suppression, and
endorsed more beliefs that taking medications
was necessary for their health. Multivariable
regression models controlling for potential
confounding factors showed that receiving
ART that requires food was significantly
related to poorer ART adherence and
unsuppressed HIV in this food insecure sample.
Conclusion: People living with HIV who are
food insecure likely experience multiple facets
of poverty that challenge their medication
adherence, but food insecurity is the only such
factor that is directly related to the
pharmacokinetics of some antiretroviral
medications. Achieving optimal treatment
outcomes for HIV infection will require
routine assessment of access to food when
determining patient-tailored ART regimens.
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INTRODUCTION
Food insecurity is a significant barrier to long-
term antiretroviral therapy (ART) in resource-
rich as well as resource-limited settings [1–3]. In
urban centers with abundant but inequitable
access to food, including in the United States
(US) and Canada, people living with HIV who
experience food insecurity are less likely to be
adherent to treatment, achieve poorer HIV viral
suppression, and have greater mortality than
their food secure counterparts [4–7]. Food
insecurity itself can interfere with medication
adherence by disrupting daily routines,
impairing memory and attention, impeding
adherence strategies, and reducing motivation
[8]. In essence, the immediacy of accessing food
to meet survival needs can understandably take
priority over adhering to medication schedules.
Patients may forego taking medications at times
when food is unavailable if they have been
instructed that their medicines should always
be taken with food. In addition to the direct
effects of food insecurity on antiretroviral
adherence, lacking food will further challenge
the clinical efficacy of ART when required to be
taken with food for maximum absorption and
clinical benefit [9].
Food is required for processing, absorption,
and optimal clinical benefits for certain ART
regimens, with pharmacokinetic studies
showing as much as a 38% increase in the
availability of some antiretrovirals when taken
with food [10, 11]. The protease inhibitor
darunavir, for example, is rapidly absorbed
and systemic exposure is increased by 30%
when taken with a meal [12, 13]. Similarly,
administration of atazanavir with a light meal
results in a 70% increase in drug plasma
concentration [14]. The bioavailability of
ritonavir, which itself is used to boost the
bioavailability of other protease inhibitors, is
also suboptimal when taken without food [15].
Similarly, taking tenofovir and rilpivirine with a
meal can mean as much as a 36% increase in
drug bioavailability [16, 17]. People who are
food insecure must therefore periodically
choose to either take their medications
knowing they are not following directed use or
miss their medications altogether when food is
unavailable. People living with HIV who
experience food insecurity may therefore have
poorer clinical outcomes as a result of both non-
adherence and insufficient absorption. In a
previous study, we found that a significant
number of people living with HIV who are
food insecure are prescribed ART that should be
taken with food and these individuals had more
HIV symptoms, lower CD4 cell counts, and
poorer HIV suppression than their counterparts
who were not prescribed ART that requires food
[18]. Given that our previous study was the first
to investigate antiretrovirals that require food
prescribed to people with HIV who are also food
insecure, the current study sought to extend
those findings in an independent sample.
The current study investigated ART
adherence and viral suppression among people
living with HIV who are food insecure in
relation to receiving ART that should be taken
with food. We extend past research that has
examined food insecurity in relation to ART
adherence by focusing on ART regimens that
require food. In addition, the current study
incudes potential confounding factors that may
account for the previously observed associations
between non-adherence and medication
requirements including side effects and
medication adherence motivational beliefs. We
hypothesized that ART adherence and HIV viral
suppression would be poorer among people
living with HIV who are food insecure and are
prescribed antiretroviral regimens that require
food compared to individuals who are food
80 Infect Dis Ther (2015) 4:79–91




Participants were men and women taking
antiretrovirals to treat their HIV infection and
had experienced food insecurity in the previous
month. The site of the study was Atlanta,
Georgia with an annual incidence of 30.3 per
100,000, exceeding the 19.6 per 100,000
population rate of HIV in major US cities.
Eligible participants were aged 18 years or
older, HIV positive, and currently taking ART.
Procedures
The study was conducted between January 2013
and March 2014. A total of 1,101 people living
with HIV were recruited through targeted
community sampling with both venue
recruitment and snowball sampling
techniques. Venue recruitment relied on
responses to brochures placed in waiting
rooms of HIV service providers and infectious
disease clinics throughout Atlanta, GA.
Participants were also encouraged to use the
project brochures to refer their HIV-positive
friends to the study. Individuals provided
informed consent prior to completing any
study activities.
Participants completed four sources of data:
audio computer-assisted self-interviews (ACASI)
to assess demographic and behavioral
characteristics at the start of the study [19,
20]; HIV RNA (viral load) and CD4 cell counts
obtained from medical records; a urine
specimen for drug screening; and
unannounced pill counts to prospectively
assess ART regimens and adherence. The
specific measures are described below. The
University of Connecticut Institutional Review
Board approved all procedures.
Measures
Computerized Interviews
Participants were asked their gender, age, years
of education, income, ethnicity, and
employment status. We also collected the year
that participants first tested HIV positive, a
measure of 14 HIV-related symptoms of 2-weeks
duration (indicated as having or not having
experienced each symptom, summed to a
composite score) [21], and experience of 11
common ART side effects (ranged between
0 = ‘‘not experiencing’’ to 3 = ‘‘severely
experiencing’’, summed to composite score)
[22]. To assess alcohol use, we administered
the Alcohol Use Disorders Identification Test
(AUDIT), a 10-item scale designed to measure
alcohol consumption and identify risks for
alcohol abuse and dependence [23]. Scores on
the AUDIT range from 0–40 and the AUDIT has
demonstrated acceptable reliability and validity
[24]. The first item on the AUDIT was used to
index frequency of alcohol use over the
previous week.
To assess food insecurity, we used items
adapted from the US Food Security Scale that
have been validated in past research and used
by the US Census Bureau [25]. The specific items
are reported in the results section. We also
included an item asking participants if they had
to decide whether to buy food or medications.
Food insecurity indicators were collected with
respect to experiences in the past month,
dichotomized (experienced/not experienced),
and summed to create a food insecurity index.
We used the Beliefs about Medicine
Questionnaire to assess participant’s
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motivations for adhering to medications [26,
27]. The medication necessity scale consists of
five items reflecting the perceived benefits of
medications in direct relation to health;
example items include ‘‘My health, at present,
depends on my medicine’’, ‘‘My life would be
impossible without my medicine’’, and ‘‘My
medicines protect me from becoming worse’’.
The five-item medication concerns scale reflects
the potential adverse effects and costs of
medication; example items include ‘‘Having to
take my medicines worries me’’, ‘‘My medicines
disrupt my life’’, and ‘‘I sometimes worry about
the long-term effects of my medicines’’. Items
are responded to on a 5-point scale,
1 = ‘‘strongly agree’’, 5 = ‘‘strongly disagree’’.
The medication necessity and concerns scales
were both internally consistent, alphas = 0.78
and 0.81, respectively.
Urine Screening for Drug Use
To objectively screen for illicit drug use, we
conducted a multi-panel urine dip test to detect
common illicit drug use. This test strip uses a
lateral flow chromatographic immunoassay for
qualitative detection of 12 drugs and drug
metabolites. These tests are Food and Drug
Administration (FDA) approved and are
reliable and valid for initial drug screening
(Reditest-12; Redwood Toxicology Laboratory,
Santa Rosa, CA, USA).
Chart Abstracted HIV Viral Load and CD4
Cell Counts
We used a participant-assisted method for
collecting chart abstracted HIV viral load and
CD4 cell counts from participants’ medical
records. Participants were given a form that
asks their physician’s office to provide the
results of their most recent HIV viral load and
CD4 cell counts and dates (not older than
3 months). These data were therefore obtained
directly by the participants from their health
care providers. The form included a place for
the provider’s office stamp or signature to assure
data authenticity. HIV RNA below detection
was defined as less than 200 copies/mL for
uniformity across providers.
ART Regimen Determination and Adherence
Participants consented to three unannounced
telephone-based pill counts that occurred over a
6-week period. Unannounced pill counts are
reliable and valid in assessing medication
adherence when conducted in homes [28] and
on cell phones [29, 30]. In this study, we
conducted unannounced cell-phone-based pill
counts. Participants were provided with a free
cell phone for use in the study assessments. An
office-based interview included a full
accounting and recording of all prescription
medications, determining ART regimen, and
systematic training in the pill counting
procedure. Participants were subsequently
called at three unscheduled times over 12- to
16-day intervals. Pharmacy information from
pill bottles was also collected to verify the
number of pills dispensed between calls.
Adherence was defined as the ratio of pills
counted relative to pills prescribed, taking into
account the number of pills dispensed. ART
adherence was examined as a continuous
variable and as a clinically defined categorical
variable with adherence defined as greater than
85% of their medications [3, 4].
Data Analyses
Of the 1,101 individuals recruited, 498 screened
positive for experiencing at least one indicator
of food insecurity (see below for exact items).
Among these participants, 481 (96%) returned
with their medical chart abstracted viral loads
and 418 (84%) completed unannounced pill
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counts for ART adherence. All participants with
adherence data also had returned with their
viral loads. Therefore, analyses were performed
on the 418 food insecure persons with
adherence data. Setting P\0.05 significance
for an odds ratio of 1 standard deviation
increase in exposure and odds ratio of 1.5 for
one standard deviation increase in a covariate
with a sample size of 418, calculations estimate
statistical power of 0.89, indicating sufficient
power for our statistical models [31, 32].
Participants were grouped on the basis of the
food requirements of their ART regimen. We
obtained recommended ART administration
instructions from antiretroviral treatment
guidelines for adults [33] and
recommendations from AIDSmeds [34]. Five
protease inhibitors and one non-nucleoside
reverse transcriptase inhibitor (NNRTI) were
recommended for administration with food;
195 participants were taking ART that did not
require food and 223 participants were taking
ART that requires food. Descriptive analyses
compared participants who were taking ART
that did not require food with those who were
taking ART that did require food. Comparisons
used contingency table Chi-square tests for
categorical variables and independent t tests
for continuous measures. To test the main study
hypothesis that participants who are prescribed
ART that requires food would have poorer ART
adherence and poorer viral suppression, we
performed separate multivariable logistic
regressions for each outcome, reporting odds
ratios with 95% confidence intervals. The
regression models controlled for factors that
are known to predict adherence (i.e., substance
use) and variables found related to ART
regimens that require food in the descriptive
analyses. All variables were continuous scaled
except employment (coded 0 = unemployed,
1 = employed), income (0 =\$10,000/year,
1 = C $10,000/year), drug use (0 = none
detected, 1 = detected), and ART regimen
requiring food (0 = does not require food,
1 = requires food). All analyses were conducted
in SPSS Statistics (version 20; IBM Corporation,
Armonk, NY, USA) and statistical significance
was defined as P\0.05.
RESULTS
Of the 418 individuals who had experienced
food insecurity in the previous month, 223
(53%) were prescribed ART that should be taken
with food. The majority of participants were
receiving regimens that included nucleoside/
nucleotide reverse transcriptase inhibitors
(NRTI) and protease inhibitors, the two largest
classes of medications. Overall, ART adherence
averaged 81% of medications taken over the
subsequent month, with considerable
variability in adherence across classes of
medications (see Table 1). Results showed that
most indicators of food insecurity were evenly
distributed among people who were not and
were prescribed ART that requires food.
However, having had to choose between
paying for food or obtaining medications
occurred significantly more often for
individuals prescribed ART that should be
taken with food (see Table 2).
Factors Associated with Receiving ART
that Requires Food
Table 3 shows the characteristics of participants
taking ART that does not and does require food.
Descriptive analyses found that individuals
taking ART that requires food were
significantly more likely unemployed, had
lower CD4 cell counts, were more likely to
have unsuppressed HIV viral loads, were living
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Table 1 Antiretroviral medications prescribed to food insecure people living with HIV
Antiretroviral medication N % M SD
Generic name Brand name
NRTI 278 67 81.2 21.5
Zidovudine ? lamivudine (AZT ? 3TC) Combivir 9 2
Emtricitabine (FTC) Emtriva 6 1
Lamivudine (3TC) Epivir 6 1
Abacavir ? lamivudine Epzicom 55 13
Zidovudine (AZT) Retrovir 13 3
Zidovudine ? lamivudine ? abacavir Trizivir 6 1
Tenofovir ? emtricitabine Truvada 183 44
Didanosine (ddI) Videx 5 1
Tenofovir Viread 15 4
Abacavir Ziagen 10 2
NNRTI 35 8 60.5 41.0
Etravirine (TMC125)a Intelencea 13 3
Efavirenz Sustiva 12 3
Nevirapine Viramune 10 2
Dual class
Efavirenz ? tenofovir ? emtricitabine Atripla 84 20 75.8 29.2
Protease inhibitor 243 58 80.4 21.5
Ritonavira Norvira 206 49
Darunavira Prezistaa 92 22
Atazanavira Reyataza 119 29
Nelﬁnavira Viracepta 2 \1
Lopinavir/ritonavir Kaletra 26 6
Fosamprenavir Lexiva 5 1
Entry inhibitor
Maraviroc Selzentry 23 6 32.2 40.0
Integrase inhibitor
Raltegravir Isentress 73 18 67.7 35.9
SD standard deviation
a Denotes medication that should be taken with food. Medications only shown if at least one participant was prescribed,
January 2013 to March, 2014
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with HIV diagnoses longer, and reported
significantly more beliefs that their
medications are necessary for their health.
There were no other differences between
individuals taking ART that requires food
verses those not taking medications that
require food.
Predictors of ART Adherence
We constructed a multivariable logistic
regression model to test the independent
effects of ART regimens requiring food on
medication adherence over the prospective
1-month period. The model included factors
that were associated with taking ART regimens
that require food including employment, years
living with HIV diagnosis, and adherence
motivation beliefs. In addition, the model
included socio-demographic and behavioral
factors that are generally known to be
associated with adherence including
education, income, substance use, and
medication side effects. Results showed that
greater alcohol use, fewer beliefs that
medications are necessary, and being
prescribed an ART regimen that requires food
significantly predicted poorer ART adherence
over and above the other factors included in the
model (see Table 4).
Table 2 Food insecurity indicators among food insecure people living with HIV prescribed antiretroviral medications that
do not and do require food







n % n %
Worried if food would run out before having money to buy more 163 84 178 80 1.22 ns
Food did not last and did not have money to get more 153 79 172 77 0.18 ns
Had to choose between paying for medicine or buying food 41 21 69 31 5.53 0.01
Adults in household cut meal size for not having money for food 106 55 117 53 0.20 ns
Ate less than felt like needed to because was not enough money 115 59 125 56 0.44 ns
Hungry without eating for not being able to afford food 72 37 96 43 1.62 ns
Adults in household not eat for a whole day without money for food 49 25 48 21 0.75 ns
Number indicators endorsed 9.1 ns
1 39 20 55 25
2 33 17 37 17
3 31 16 23 10
4 33 17 31 14
5 26 13 48 22
6 33 17 29 13
Mean (SD) indicators 3.3 1.7 3.3 1.8
ART antiretroviral therapy, ns not signiﬁcant, SD standard deviation
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Predictors of HIV Suppression
A second multivariable logistic regression
model tested the independent effects of ART
regimens requiring food on chart abstracted
HIV viral load. The model included all of the
factors described above for the adherence
model. Table 5 shows that participant
unemployment, greater beliefs about concerns
over medications, and being prescribed an ART
regimen that requires food significantly
predicted having unsuppressed (detectable)
HIV viral load, over and above the other
factors included in the model.
Table 3 Characteristics of food insecure people living with HIV prescribed antiretroviral medications that do not and do
require food
Characteristics Food not required with ART
(N5 194)
Food required with ART
(N5 223)
X2 P
n % n %
Male 141 72 172 77
Female 53 27 51 22 1.09 ns
African American 178 91 204 92 3.90 ns
Unemployed 164 84 200 90 9.83 0.05
Income\$10,000 128 66 154 69 0.82 ns
CD4\200 cell/mL 22 12 60 27 16.45 0.01
Antiretroviral adherence\75% 50 26 70 31 1.68 ns
Antiretroviral adherence\85% 77 40 104 47 2.16 ns
Antiretroviral adherence\95% 123 63 157 70 2.52 ns
Viral load detectable 35 18 62 28 5.89 0.01
Alcohol use 127 65 136 61 2.57 ns
Drug use 117 60 138 62 0.56 ns
Characteristics M SD M SD T P
Age 44.3 11.1 44.7 9.6 0.38 ns
Years of education 12.5 1.7 12.8 1.5 1.57 ns
Years since HIV diagnosis 12.1 7.6 13.9 8.1 2.33 0.05
HIV symptoms 4.0 3.2 4.5 3.6 1.59 ns
Medication side effects 0.51 0.44 0.55 0.49 0.70 ns
Antiretroviral medication adherence 83.3 18.5 80.5 20.1 1.48 ns
CD4 cell count 533.5 273.5 393.3 278.5 5.10 0.01
AUDIT alcohol 13.9 11.5 13.6 11.5 0.30 ns
Medication necessity 20.9 4.0 21.7 3.4 1.98 0.05
Medication concerns 14.5 4.7 14.0 4.5 0.97 ns
ART antiretroviral therapy, AUDIT Alcohol Use Disorders Identiﬁcation Test, ns not signiﬁcant
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DISCUSSION
In recently published Antiretroviral Treatment
of Adult HIV Infection Recommendations, the
International AIDS Society (IAS) reviewed the
many benefits of HIV treatment and provided
guidelines for achieving optimal clinical
outcomes [35]. Recommendations are focused
on settings where ARTs are available,
particularly resource-rich countries. Guidance
for ART takes into consideration multiple
patient and regimen characteristics including
efficacy, toxicity, pill burden, dosing, viral
resistance, comorbid conditions, and cost.
However, a significant omission from
consideration in selecting an ART regimen is
the patient’s access to sufficient and reliable
food sources. In the current study of people
living with HIV who experience food insecurity,
we found that more than half were prescribed
ART that should be taken with food. The
prevalence of multiple indicators of food
insecurity was evenly distributed among
individuals who were prescribed ART that does
and does not require food, including more than
one-third experiencing hunger in the previous
month. However, the one factor that was
associated with taking ART that requires food
was having had to choose between obtaining
medications and paying for food in the previous
month. This finding speaks to the complexity of
managing scarce resources in meeting the
demands of medications that must be taken
with food among people who are food insecure.
Unlike other challenges to ART adherence
among the poor, the dilemma posed by
medications with food requirements is
resolvable by either prescribing an ART
regimen that does not require food, when
appropriate and feasible, or assuring that
patients are provided food to be taken with
their medication.
Table 4 Logistic regression model predicting 85% ART




Education 0.97 ns 0.86–1.10
Employment 1.05 ns 0.84–1.32
Income 1.19 ns 0.88–1.62
Years since HIV diagnosis 1.01 ns 0.98–1.04
Alcohol use 0.76 0.01 0.63–0.91
Screen positive for drug use 0.73 ns 0.46–1.14
Medication side effects 1.40 ns 0.87–2.27
Medication necessity beliefs 1.08 0.01 1.01–1.14
Medication concerns beliefs 0.96 ns 0.91–1.01
Number of food insecurity
indicators
1.02 ns 0.91–1.16
ART requires food 0.65 0.05 0.42–0.99
ART antiretroviral therapy, CI conﬁdence interval, ns not
signiﬁcant, OR odds ratio





Education 0.89 ns 0.76–1.03
Employment 0.72 0.05 0.54–0.95
Income 0.91 ns 0.61–1.36
Years since HIV diagnosis 0.98 ns 0.95–1.01
Alcohol use 1.01 ns 0.80–1.26
Screen positive for drug use 1.65 ns 0.91–2.95
Medication side effects 1.58 ns 0.91–2.71
Medication necessity beliefs 0.99 ns 0.93–1.07
Medication concerns beliefs 1.08 0.01 1.02–1.15
Number of food insecurity
indicators
1.08 ns 0.93–1.25
ART requires food 2.34 0.01 1.35–4.04
ART antiretroviral therapy, CI conﬁdence interval, ns not
signiﬁcant, OR odds ratio
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In many cases, providers will have fewer
medication options for patients who have a
history of poor adherence and those patients
who have been treated longer with ART. These
clinical realities may explain the patterns of
results in this study. Patients who are food
insecure also demonstrate poorer adherence
and may therefore develop resistance, leaving
fewer treatment options. In addition, not all
ART regimens are equally accessible through
various drug assistance programs. Thus, even
when providers are aware of the conflict
between food insecurity and prescribing ART
that requires food, their best treatment option
may be a regimen that requires food for optimal
absorption. In addition, programs that provide
nutritional support and meals to patients are
scarce in many settings. Again, even when
providers are aware of patient food insecurity
there are limits to their ability to provide food.
These clinical realities, therefore, present
clinical dilemmas that can only be resolved
with access to more affordable treatment
options and increased meal services for
patients in need.
These findings should be interpreted in light
of the study limitations. First, we relied on a
convenient sample that cannot be considered
representative of people living with HIV
infection. The sample also came from a wide
range of providers that likely varied in health
services and prescription practices. While we
had objective measures of ART regimens,
adherence, current substance use, and clinical
health status (CD4 count and viral load), our
study relied on self-report instruments to assess
social and behavioral characteristics, including
food insecurity. Although we used reliable and
valid measures, self-report data may still be
subject to social response biases. In addition,
we grouped all medications that require food
into one class despite the variable importance
of food for the absorption of any single
medication. Our data also do not allow
precise measurement of whether missed
medication doses occurred in relation to
times when food was scarce, particularly
whether medications that are instructed to be
taken with food are missed at those times.
Future research may use event/dose level
medication monitoring with time-linked
measures of food intake to determine more
precise associations. With these limitations in
mind, we believe that our findings have
implications for treatment guidelines, clinical
practice and future research.
CONCLUSION
Given that HIV is embedded in a context of
poverty, access to food should be formally
assessed and explicitly considered when
prescribing ART. Patients should not be
expected to overcome the shame and stigma
of not having food to initiate this conversation.
In addition to the obvious necessity of nutrition
in health, access to food is known to improve
adherence [36–38]. The importance of food in
health takes on a new dimension when the
bioavailability of medications depends on food.
Treatment guidelines cannot address every issue
facing providers and patients in selecting
treatment regimens. However, requiring food
for optimal absorption is the only aspect of
poverty directly related to the pharmacokinetics
of ART. Failing to address adequate access to
food when selecting ART regimens will
undermine the clinical care of a significant
and growing population of HIV infection
patients living in poverty.
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